Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Study: British South Asians more likely to be severely depressed following cancer diagnosis

The first study of its kind to investigate depression following cancer diagnosis among British white people and South Asians in the UK has discovered that South Asians are five times more likely to be severely depressed.

17 Jun 2013

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Genmab A/S and ADC Therapeutics Sarl, announced today an agreement to develop a new antibody-drug conjugate product combining Genmab's HuMax-TAC antibody and ADC Therapeutics' PBD-based warhead and linker technology.

17 Jun 2013

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.

17 Jun 2013

Bristol-Myers Squibb, AstraZeneca release statement on ADA's efforts toward incretin-based therapies

Earlier this week, the American Diabetes Association called for manufacturers of incretin-based therapies to make patient-level data available from clinical trials for an independent analysis of pancreatic safety.

17 Jun 2013

Google to feature health-centered Google+ Hangouts for International Men's Health Month

Google, in partnership with WireBuzz.com and Prevention.com, will feature a series of health-centered Google+ Hangouts for International Men's Health Month. The live discussions will build awareness around men's health issues including diet and exercise, cancer, sexual health and more.

15 Jun 2013

Dosimetry based on 3-D medical images estimates possible dose for targeted RIT in blood cancer patients

Outcomes can be bleak for non-Hodgkin lymphoma (NHL), a cancer that develops in the white blood cells of the immune system. Accurate estimation of radiation absorbed dose in radioimmunotherapy (RIT) based on state-of-the-art 3D imaging could lead to more personalized and effective treatments to improve patients' chances of living longer without progression of their cancer, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

15 Jun 2013

Teva to present abstracts on AZILECT at MDS meeting

Teva Pharmaceutical Industries Ltd. announced today that a number of abstracts will be presented during the 17th Annual International Congress of Parkinson's Disease and Movement Disorders in Sydney, Australia, June 16-20, 2013, also known as the Movement Disorders Society.

15 Jun 2013

Gene variants may predict which women are most likely to benefit from breast cancer therapy

In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.

14 Jun 2013

Johns Hopkins scientists receive grants to research on genome-based test for cancer

An anonymous donor has given $500,000 to conduct large-scale clinical trials and laboratory research on the "PapGene" test, a genomic-based screening test that detects ovarian and endometrial cancers in cervical fluid.

14 Jun 2013

Society of Interventional Radiology adds 18 Fellows to its roster

The Society of Interventional Radiology (SIR) announced the addition of 18 Fellows to the Fairfax, Virginia-based, national organization's roster during SIR's 38th Annual Scientific Meeting, held April 13 in New Orleans.

14 Jun 2013

Data demonstrate benefits of nurse-led programme on patient self-management of RA

Data first presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism demonstrate the benefits of a nurse-led programme on patient self-management and the management of rheumatoid arthritis co-morbidities.

14 Jun 2013

Findings provide basis for reinvigoration of research efforts in breast cancer prevention

Genetic variations, known as single nucleotide polymorphisms, in or near the genes ZNF423 and CTSO were associated with breast cancer risk among women who underwent prevention therapy with tamoxifen and raloxifene, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.

14 Jun 2013

Xgeva receives FDA approval for treating giant cell tumor of the bone

The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone, a rare and usually non-cancerous tumor.

14 Jun 2013

PRISM Pharma announces closing of $15 million Series C financing

PRISM Pharma Co., Ltd., a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, today announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.

13 Jun 2013

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Although several chemotherapy treatments are now administered by the oral route (targeted chemotherapy), most chemotherapy treatments (cytotoxics) are administered by the intravenous route.

13 Jun 2013

Society of Interventional Radiology releases Updates in Interventional Radiology 2013

The Society of Interventional Radiology announces the release of "Updates in Interventional Radiology 2013," a concise reference of the current literature most relevant to the specialty.

13 Jun 2013

Black women with breast cancer experience treatment delays, new study finds

Black women with breast cancer are more likely than Hispanic or white women to experience delays in the initiation of chemotherapy or radiation after surgery, finds a new study in Health Services Research.

13 Jun 2013

Researcher improves segmentation technique of PET images

Elena Prieto-Azkarate, a graduate in Telecommunications Engineering at the NUP/UPNA-Public University of Navarre and member of the Nuclear Medicine Service of the University College Hospital of Navarre, has implemented 12 algorithms to process medical images produced by means of PET (Positron Emission Tomography).

13 Jun 2013

Study reveals radioimmunotherapy can improve survival rates of patients with aggressive lymphoma

A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

12 Jun 2013

Researchers find cancer guidelines do not meet all the standards set by IOM

Researchers at the University of Michigan Comprehensive Cancer Center looked at 169 cancer clinical practice guidelines for lung, breast, prostate and colorectal cancers and found that none of the guidelines fully met standards set in 2011 by the Institute of Medicine. Of eight criteria, the guidelines on average met fewer than three.

12 Jun 2013

Oncology News and Research

Further Reading

Study: British South Asians more likely to be severely depressed following cancer diagnosis

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

Bristol-Myers Squibb, AstraZeneca release statement on ADA's efforts toward incretin-based therapies

Google to feature health-centered Google+ Hangouts for International Men's Health Month

Dosimetry based on 3-D medical images estimates possible dose for targeted RIT in blood cancer patients

Teva to present abstracts on AZILECT at MDS meeting

Gene variants may predict which women are most likely to benefit from breast cancer therapy

Johns Hopkins scientists receive grants to research on genome-based test for cancer

Society of Interventional Radiology adds 18 Fellows to its roster

Data demonstrate benefits of nurse-led programme on patient self-management of RA

Findings provide basis for reinvigoration of research efforts in breast cancer prevention

Xgeva receives FDA approval for treating giant cell tumor of the bone

PRISM Pharma announces closing of $15 million Series C financing

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Society of Interventional Radiology releases Updates in Interventional Radiology 2013

Black women with breast cancer experience treatment delays, new study finds

Researcher improves segmentation technique of PET images

Study reveals radioimmunotherapy can improve survival rates of patients with aggressive lymphoma

Researchers find cancer guidelines do not meet all the standards set by IOM

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News